EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Splinting for Stabilizing Peripheral Intravenous Cannula in Neonates: A Randomized Controlled Trial

Ashish Rajeshwar Dongara, Vivek Vijayamadhavan, Torbjorn Hertzberg, Ravi Prakash Agarwal

Neonatology · 2025

DOI: 10.1159/000547952 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neonatology, 2025. Verfasst von Ashish Rajeshwar Dongara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Sheikh Khalifa Medical City Ajman, Ajman, United Arab Emirates, dongaraashish@yahoo.co.in. Hauptthemen laut MEDLINE: Splints, Catheterization, Peripheral, Cannula. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

As many as 40–100% of the neonates admitted to a neonatal intensive care unit (NICU) require peripheral intravenous (PIV) cannulation, for varying reasons. Though unproven, splinting is conventionally thought to increase the lifespan of the cannula. The objective of this study was to determine whether standard fixation without splinting, after cannula insertion near a joint, influences its lifespan.

Methods

This unmasked, parallel group, randomized controlled trial was approved by the Hospital Ethics Committee. Eligible PIV cannula insertions were divided into: “No Splint” and “Splint” group. In the “Splint group” after standard fixation of the PIV, a readymade splint was used. Written informed consent was obtained from parents. The primary outcome was measured as difference in the lifespan of the PIV cannula in both the groups.

Results

We enrolled 341 cannulations in “No Splint” and 344 in “Splint” group. The demographic details of both the groups were comparable. Mean gestational age, age at time of enrollment, and birthweight was 33+3 weeks, 3.4 days and 2,160 g, respectively. The mean (95% confidence interval) life of PIV cannula in the “No splint” and the “Splint” groups were 48.5 (45.1, 52.2) and 47.5 (43.6, 51.3) hours (p value 0.7), respectively. Subgroup analysis showed longer PIV cannula life in “No Splint” group neonates who were term and weighed ≥2,500 g.

Conclusion

In neonates with a PIV cannula placed over a joint, standard fixation without splinting did not shorten the cannula life. Not splinting may be associated with increased lifespan of the PIV cannula in term, normal birthweight neonates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SplintsCatheterization, PeripheralCannulaHumansInfant, NewbornFemaleMaleIntensive Care Units, NeonatalGestational Age

Stichwörter der Autor:innen

Intravenous cannulationNeonatal intensive care unitNeonatesSplinting

Autor:innen und Institutionen

  • Department of Neonatology, Sheikh Khalifa Medical City Ajman, Ajman, United Arab Emirates, dongaraashish@yahoo.co.in.
  • Department of Neonatology, Sheikh Khalifa Medical City Ajman, Ajman, United Arab Emirates.

Zitieren

APA

Dongara, A. R., Vijayamadhavan, V., Hertzberg, T., & Agarwal, R. P. (2025). Splinting for Stabilizing Peripheral Intravenous Cannula in Neonates: A Randomized Controlled Trial. Neonatology. https://doi.org/10.1159/000547952

Vancouver

Dongara AR, Vijayamadhavan V, Hertzberg T, Agarwal RP. Splinting for Stabilizing Peripheral Intravenous Cannula in Neonates: A Randomized Controlled Trial. Neonatology. 2025. doi:10.1159/000547952

BibTeX
@article{Dongara2025,
  author = {Dongara, Ashish Rajeshwar and Vijayamadhavan, Vivek and Hertzberg, Torbjorn and Agarwal, Ravi Prakash},
  title = {Splinting for Stabilizing Peripheral Intravenous Cannula in Neonates: A Randomized Controlled Trial},
  journal = {Neonatology},
  year = {2025},
  doi = {10.1159/000547952}
}
Kostenlos starten →